The 2022 Updates in GI Educational Conference will deliver focused, educational updates highlighting clinically relevant advances in the management of patients with gastrointestinal (GI) disorders and chronic liver disease (CLD). It will feature an interactive format to enhance the educational impact.
Internationally renowned gastroenterologists and hepatologists will lead the development of educational content and will serve as program faculty. The faculty will review state-of-the-art developments in gastrointestinal (GI) disorders and chronic liver disease (CLD), including, but not limited to:
Inflammatory Bowel Disease (IBD)
Irritable Bowel Syndrome (IBS)
Alternative Medicine & Diet in GI
Clostridioides difficile (C. diff)
Hepatic Encephalopathy (HE)
Hepatorenal Syndrome (HRS)
IBS with Alternating Constipation and Diarrhea
(IBS C and D)
/ CME AGENDA TOPICS
THURSDAY, OCTOBER 20, 2022
6:30 – 7:30 PM
Exhibits and Welcome Reception
7:30 – 8:30 PM
CME Dinner Symposium
8:30 – 10:00 PM
Exhibits - Reception
FRIDAY, OCTOBER 21, 2022
7:00 – 8:00 AM
Breakfast / Exhibits
8:00 – 8:45 AM
Endoscopic Obesity Management
The Psychosocial Component of Health in IBS and IBD
Alternative Medicine & Diet in GI Disorders
Hemorrhoid Treatments, Including Banding
12:45 – 1:45 PM
CME Lunch / Industry-Sponsored Event
APP CME Event
Breaking News in the Management of HRS-AKI
HE Transition of Care
C. difficile management Updates
Management of Acute Pancreatitis / Complications
Management of IBS C and D
6:00 – 8:00 PM
*This agenda is subject to change.
† Exclusive sponsorship.
/ COURSE DIRECTORS
Raj Devarajan, MD
Gastro Health Massachusetts
George Dickstein, MD, FASGE, AGAF
Gastroenterologist and Vice President of Clinical Affairs,
Gastro Health Massachusetts
Eugenio J. Hernandez, MD
Gastroenterologist and Senior Vice President of Clinical Affairs
Gastro Health Florida
Upon completion of this educational activity, participants should be able to:
Describe current screening, diagnosis, and management options for patients with
gastrointestinal (GI) disorders and chronic liver disease (CLD)
Apply optimal treatment strategies for patients with GI disorders and CLD
Compare and contrast currently available treatment modalities for GI disorders and CLD
For details on sponsorship opportunities, please contact:
Manager, Business Development
7 Century Drive, Suite 102
Parsippany, NJ 07054
/ CME accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Focus Medical Communications. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All faculty and staff involved in the planning or presentation of continuing education activities provided by the University of Cincinnati are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.
All additional planning committee members, the University of Cincinnati staff and Focus Medical Communications staff have no relationships to disclose.
Learner Assurance Statement
The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.
Off-Label Disclosure Statement
Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.
Americans With Disabilities Act
The event staff will be glad to assist you with any special needs (ie, physical, dietary). Please contact us prior to the event at 1-877-782-4532.